mibefradil has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Huang, W; Lu, C; Ouyang, S; Wu, Y | 1 |
1 other study(ies) available for mibefradil and Leukemia
Article | Year |
---|---|
T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines.
Topics: Apoptosis; Benzimidazoles; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopropanes; Endoplasmic Reticulum; Humans; Leukemia; Leukocytes, Mononuclear; MAP Kinase Signaling System; Mibefradil; Naphthalenes | 2015 |